Prescription Drug Pricing Act would save more than $94 billion in the first decade, CBO says

Healthcare Finance: The Prescription Drug Pricing Act, penned by Senator Charles Grassley, R-Iowa, and co-sponsored by Senator Ron Wyden, D-Oregon, is in a weird state of limbo, sitting on the Senate's legislative calendar for months. But if and when it ever passes, it could stand to save billions.

Based on estimates from the Congressional Budget Office, the bill could save more than $94 billion over the next 10 years, due in part to strict price reporting controls on pharmaceutical companies and the continuance of drug manufacturer rebates.

Read article